Press Releases
Annonce du thème de la 8e édition de la Future Investment Initiative: “Infinite Horizons: Investir aujourd’hui…bâtir demain”
RIYAD, Arabie saoudite, 30 avr. 2024 (GLOBE NEWSWIRE) — Le Future Investment Initiative Insitute est heureux d’annoncer le thème de la 8e édition de sa conférence FII, prévue du 29 au 31 octobre 2024 au prestigieux Centre international de conférences
Apresentando o tema do 8º Fórum do Future Investment Initiative: “Horizontes Infinitos: Investindo Hoje, Moldando o Amanhã”
RIYADH, Arábia Saudita, April 30, 2024 (GLOBE NEWSWIRE) — O Future Investment Initiative (FII) Institute tem o prazer de anunciar o tema para a próxima 8ª edição da conferência FII, que acontecerá entre os dias 29 a 31 de outubro
One Za’abeel launches The Offices, Dual Licensed Office Space in One Za’abeel Tower
DUBAI, United Arab Emirates, April 30, 2024 (GLOBE NEWSWIRE) — One Za’abeel, the iconic mixed-use development developed by ICD (Investment Corporation of Dubai), is pleased to announce the launch of The Offices, its ultra-luxurious dual licensed corporate office spaces in
EAACI Congress 2024: Innovation and Advances in Allergy Treatment
EAACI Congress 2024 Over 150 scientific sessions will be presented during the congress, focusing on advancements in environmental science, food allergies, innovations in immunotherapy, and pediatric allergies, among others. Precision medicine, AI, immunotherapy, and immune modulators will converge at the
Congresso da EAACI 2024: Inovação e Avanços no Tratamento da Alergia
EAACI Congress 2024 Durante o congresso serão apresentadas mais de 150 sessões científicas, centradas nos avanços da ciência ambiental, alergias alimentares, inovações em imunoterapia e alergias pediátricas, entre outras. A medicina de precisão, a IA, a imunoterapia e os moduladores
Congrès EAACI 2024 : innovations et progrès dans le traitement des allergies
EAACI Congress 2024 Lors de ce congrès, plus de 150 sessions scientifiques seront présentées. Les sujets abordés se concentreront sur les progrès de la science environnementale, les allergies alimentaires, les innovations en matière d’immunothérapie et les allergies pédiatriques, entre autres.
Rakshit Choudhary : de directeur des opérations à co-PDG de Deriv
Rakshit Choudhary, promu co-PDG, collaborera avec le fondateur et PDG Jean-Yves Sireau Deriv donne un coup de neuf à son modèle de leadership à l’approche de la célébration de son 25e anniversaire Rakshit Choudhary : de directeur des opérations à
Deriv promotes Rakshit Choudhary from COO to co-CEO
Rakshit Choudhary promoted to co-CEO Rakshit Choudhary promoted to co-CEO, partnering with Founder and CEO Jean-Yves Sireau Deriv refreshes its leadership model as it gets set to celebrate its 25th anniversary Rakshit Choudhary, co-CEO of Deriv CYBERJAYA, Malaysia, April 26,